The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

被引:172
作者
Bien, Justyna [2 ]
Palagani, Vindhya [1 ]
Bozko, Przemyslaw [1 ]
机构
[1] Univ Tubingen, Dept Internal Med 1, Fac Med, D-72076 Tubingen, Germany
[2] Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland
关键词
Clostridium difficile; inflammatory bowel disease; microbial dysbiosis; 16S RIBOSOMAL-RNA; NF-KAPPA-B; ACID-SUPPRESSIVE AGENTS; TOXIN-B; SIGNALING PATHWAYS; FECAL MICROBIOTA; EGF RECEPTOR; ACTIVATION; DIVERSITY; DIARRHEA;
D O I
10.1177/1756283X12454590
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gut microbiota is a compilation of microorganisms dwelling in the entire mammalian gastrointestinal tract. They display a symbiotic relationship with the host contributing to its intestinal health and disease. Even a slight fluctuation in this equipoise may be deleterious to the host, leading to many pathological conditions like Clostridium difficile infection or inflammatory bowel disease (IBD). In this review, we focus on the role of microbial dysbiosis in initiation of C. difficile infection and IBD, and we also touch upon the role of specific pathogens, particularly C. difficile, as causative agents of IBD. We also discuss the molecular mechanisms activated by C. difficile that contribute to the development and exacerbation of gastrointestinal disorders.
引用
收藏
页码:53 / 68
页数:16
相关论文
共 131 条
[1]   Distal gut microbiota of adolescent children is different from that of adults [J].
Agans, Richard ;
Rigsbee, Laura ;
Kenche, Harshavardhan ;
Michail, Sonia ;
Khamis, Harry J. ;
Paliy, Oleg .
FEMS MICROBIOLOGY ECOLOGY, 2011, 77 (02) :404-412
[2]   Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease [J].
Alberto, Luis ;
Rodriguez, Garcia ;
Ruigomez, Ana ;
Panes, Julian .
GASTROENTEROLOGY, 2006, 130 (06) :1588-1594
[3]   Quasiexperimental Study of the Effects of Antibiotic Use, Gastric Acid-Suppressive Agents, and Infection Control Practices on the Incidence of Clostridium difficile-Associated Diarrhea in Hospitalized Patients [J].
Aldeyab, Mamoon A. ;
Harbarth, Stephan ;
Vernaz, Nathalie ;
Kearney, Mary P. ;
Scott, Michael G. ;
Funston, Chris ;
Savage, Karen ;
Kelly, Denise ;
Aldiab, Motasem A. ;
McElnay, James C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) :2082-2088
[4]   Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease [J].
Ananthakrishnan, A. N. ;
McGinley, E. L. ;
Binion, D. G. .
GUT, 2008, 57 (02) :205-210
[5]   Host-bacterial mutualism in the human intestine [J].
Bäckhed, F ;
Ley, RE ;
Sonnenburg, JL ;
Peterson, DA ;
Gordon, JI .
SCIENCE, 2005, 307 (5717) :1915-1920
[6]   Effect of amoxicillin-clavulanic acid on human fecal flora in a gnotobiotic mouse model assessed with fluorescence hybridization using group-specific 16S rRNA probes in combination with flow cytometry [J].
Barc, MC ;
Bourlioux, F ;
Rigottier-Gois, L ;
Charrin-Sarnel, C ;
Janoir, C ;
Boureau, H ;
Doré, JL ;
Collignon, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1365-1368
[7]   Nuclear factor kappa B [J].
Barnes, PJ .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (06) :867-870
[8]   C3 toxin activates the stress signaling pathways, JNK and p38, but antagonizes the activation of AP-1 in rat-1 cells [J].
Beltman, J ;
Erickson, JR ;
Martin, GA ;
Lyons, JF ;
Cook, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (06) :3772-3780
[9]   Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases [J].
Bernstein, Charles N. ;
Shanahan, Fergus .
GUT, 2008, 57 (09) :1185-1191
[10]   CLOSTRIDIUM-DIFFICILE IN TOXIC MEGACOLON COMPLICATING ACUTE INFLAMMATORY BOWEL-DISEASE [J].
BOLTON, RP ;
READ, AE .
BRITISH MEDICAL JOURNAL, 1982, 285 (6340) :475-476